Healthcare Industry News: electrocardiograph
News Release - May 13, 2009
TR Design launches NewCardio brand at Heart Rhythm 2009
ANDOVER, MA – May 12, 2009 – (HSMN NewsFeed) - TR Design, in collaboration with Brian Flood Inc., has developed branding and messaging for Silicon Valley-based NewCardio Inc. (OTC BB: NWCI) and its proprietary 3D electrocardiography (ECG) platform.The team helped to define NewCardio’s core messages aimed at clinical and research audiences and created a distinctive brand design to set NewCardio apart in the cardiac safety, urgent care, and chronic care markets. The new positioning and brands will be unveiled at Heart Rhythm 2009 with a new trade show exhibit and marketing collateral.
“TR Design had the experience in the medical industry, and the branding and marketing expertise that we needed to prepare for our first major tradeshow, Heart Rhythm 2009,” said Mr. Vincent Renz, NewCardio’s president and chief operating officer. “Our 3D technology brings a new dimension to the way the medical world looks at ECGs, the most widely used diagnostic test in cardiology. We needed a brand image and vocabulary that reflected the impact we expect to have on the marketplace, and TR Design delivered.”
NewCardio is introducing the NewCardio platform, QTinno(TM) and Visual3Dx(TM) at Heart Rhythm 2009. QTinno(TM) is the industry’s first solution that accurately automates the analysis of ECGs used to determine cardiac toxicity during drug development. Visual3Dx(TM) will generate 3D information from the heart using standard 12-lead ECG data. It is expected to provide clinicians additional information on the extent and location of damage to the heart caused by a myocardial infarction to improve the speed and accuracy of diagnosis.
Heart Rhythm 2009 takes place May 13-16, 2009 in Boston, MA. The Annual Scientific Sessions attract more than 9,000 professionals representing the allied specialties of cardiac pacing and cardiac electrophysiology.
About TR Design
TR Design is a leading strategic design firm focused on the medical device market. The company helps developers of innovative products craft their strategies, position their offerings and build their brands. Their website, http://www.trdesign.com/, shares expertise in blogs written by Carroll Ray and Paul Tepperman, principals at the firm, as well as in Designochology, a monthly eNewsletter.
About Brian Flood, Inc.
Brian Flood has been an advertising writer for more than 20 years. He has created award-winning campaigns for a wide range of consumer and business brands. He can be reached via his website www.FloodCopy.com.
About NewCardio Inc.
NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio’s development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio’s three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit www.newcardio.com.
Source: TR Design
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
